Jump to content

Search the hub

Showing results for tags 'Menopause'.


More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • Patient Safety Learning news archive
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End


Group


First name


Last name


Country


Join a private group (if appropriate)


About me


Organisation


Role

Found 48 results
  1. News Article
    The link between menopause and poor mental health should be reviewed, the health watchdog has said, after an inquiry into a woman’s suicide found staff lack training to spot the risks. Frances Wellburn, 56, took her own life in 2020 after she was incorrectly assessed as being a “medium risk” of suicide by Tees, Esk and Wear NHS Trust (TEWV). A national study by the Health and Safety Investigation Branch (HSIB), prompted by her death, warned that this was a national problem, with funding and capacity problems driving staff to use ineffective “checklist” tools when assessing suicidal patients. HSIB also found staff were not trained to spot mental health risks associated with menopause, and menopause is not routinely considered a contributing factor among women with low mood who need help. It said that women are often prescribed antidepressants when hormone replacement therapy (HRT) would be more appropriate. In Ms Wellburn’s case, HSIB found TEWV staff had failed to take into account that she was going through menopause when they assessed her as being at medium risk of self-harm. This went against national guidance, which states scales should not be used to predict future suicide or self-harm. Read full story Source: The Independent, 23 March 2023
  2. Content Article
    Findings While national guidance says that a patient’s risk of harm should not be stratified into categories such as high, medium or low, such stratification remains common in many trusts. This is because other methods of assessing and documenting risk are not available, and because staff fear being blamed if a patient comes to harm without a risk assessment, including risk stratification, having been completed. Current research only demonstrates a link between menopause and low mood, and not between menopause and more severe mental health symptoms. Women are frequently prescribed antidepressant medication when hormone replacement therapy may be a more appropriate treatment for their symptoms. Menopause is not routinely considered as a contributing factor in women with low mood who are assessed by mental health services, and staff do not receive training in this area as standard. While there is a significant amount of national guidance relating to family engagement when treating patients with mental health conditions, mental health practitioners often find it difficult to know how and when to engage with families with complicated relationships or when the patient withdraws their consent for information sharing. There is a lack of training in this area to support staff with decision making. National guidance raised the upper age limit for referral to the Early Intervention in Psychosis pathway in 2016. Some trusts continue to prioritise younger patients for a variety of reasons – including funding, capacity and misconceptions about whether an older person can actually be experiencing a true first episode of psychosis in later life. Safety recommendations HSIB has made four safety recommendations as a result of this investigation. NHS England: HSIB recommends that NHS England works with appropriate stakeholders, including experts with appropriate experience, to create guidance on culture change. A quality improvement programme should also be developed to support practitioners in undertaking psychosocial assessments that are in line with guidance from the National Institute for Health and Care Excellence. Person-centred safety planning should be embedded within the process. Care Quality Commission (CQC): HSIB recommends that the Care Quality Commission evaluates the way in which it reviews how community mental health services assess risk of harm, to ensure its inspections are in line with the latest national guidance. National Institute for Health and Care Excellence (NICE): HSIB recommends that the National Institute for Health and Care Excellence evaluates the available research relating to the risks associated with menopause on mental health and if appropriate, updates existing guidance. Royal College of Psychiatrists (RCPsych): HSIB recommends that the Royal College of Psychiatrists forms a working group with relevant stakeholders to identify ways in which menopause can be considered during mental health assessments. Safety observations HSIB has made the following safety observations: It may be beneficial for mental health organisations to have a dedicated liaison officer who acts as a point of contact for both families and clinicians when navigating involvement in a patient’s care and decision making. It may be beneficial for organisations to involve families in care planning and assessments, and that practitioners are appropriately trained in working with families. It may be beneficial for education bodies to develop training programmes in safety planning and psychosocial assessments, once NHS England has provided guidance on how such assessments should be conducted. It may be beneficial for mental health organisations to ensure their Early Intervention in Psychosis referral process is in line with the national guidance, and that staff are clear about the upper age limit of patients accepted onto the pathway. Safety actions HSIB has noted the following safety action: NHS England has written to all mental health trusts in England to highlight the importance of taking a person-centred approach to psychosocial assessments and safety planning. The communication asks trusts to move away from risk assessment tools that stratify an individual’s risk of suicide or self-harm.
  3. News Article
    Hundreds of thousands of women could benefit from cheaper hormone replacement therapy (HRT) as part of a scheme to cut prescription costs. The Department of Health said that from April, women prescribed HRT as part of menopause treatment will be able to access a new scheme to enable access to a year’s worth of treatment for just under £20. The announcement follows the publication of the government’s women’s health strategy for England last summer. Minister for Women Maria Caulfield said: “Around three-quarters of women will experience menopause symptoms, with one-quarter experiencing severe symptoms, which can seriously impact their quality of life. “Reducing the cost of HRT is a huge moment for improving women’s health in this country, and I am proud to be announcing this momentous step forward. “In our Women’s Health Strategy, we made menopause a top priority – by making HRT more accessible, we’re delivering on our commitment to women.” Read full story Source: The Independent, 21 February 2023
  4. News Article
    Private menopause clinics are prescribing HRT at "twice the recommended dose", an investigation has revealed. The investigation by The Pharmaceutical Journal has revealed that patients attending private menopause clinics are subject to “unorthodox prescribing” by providers. Many are receiving oestrogen at up to double the recommended dose placing them at higher risk of cancer and vaginal bleeding. Nuttan Tanna, a pharmacist consultant in women’s health at London North West University Healthcare NHS Trust, said she had seen referrals for “bleeding investigations” and then found the patient was on "very large doses [of oestrogen] prescribed previously by private providers”. Brendon Jiang, a senior clinical pharmacist for North Oxfordshire Rural Alliance Primary Care Network, said that his team were increasingly getting letters from private clinics requesting for patients to be prescribed doses of oestrogen that are off-label or exceed licensed recommendations. He also raised concerns that patients were not taking enough progesterone alongside increased doses of oestrogen. Taking increased doses of oestrogen alone can increase the risk of womb cancer but progesterone protects against that risk and therefore the two hormones should be taken together. Read full story (paywalled) Source: The Telegraph, 19 December 2022 Further reading on the hub: Surgical menopause: a toolkit for healthcare professionals (British Menopause Society) Menopause Support - Getting the most out of your doctor’s appointment World Menopause Day 2022: Raising awareness of surgical menopause All-Party Parliamentary Group on Menopause: Inquiry to assess the impacts of menopause and the case for policy reform - conclusions
  5. News Article
    Hospital staff in Nottingham have said they are keen to build on the success of its menopause support scheme. Nottingham University Hospitals Trust (NUH) said 24% of its staff were aged 45-55, the most common age for the condition. Staff can ask for lighter uniforms, shift changes, more time to complete tasks or access to fans in offices. Advice, awareness training and access to specialist staff are also part of the scheme. The staff wellbeing team at NUH said they were "inundated" with messages from colleagues who were struggling. Jenny Good, NUH Staff Wellbeing Lead, said: "We strongly believe that menopause is an issue for everybody. Everyone knows somebody who will go through it. "We wanted to equip everyone who works at NUH with an awareness of what menopause is. "We're really proud that we're the first NHS trust to get the accreditation. "The conversation has opened up." Read full story Source: BBC News, 18 December 2022
  6. News Article
    Menopausal women working in NHS England will be able to work flexibly should they need to under new guidance. Launching the first national NHS guidance on menopause, the NHS England chief executive, Amanda Pritchard, has called on other employers to follow suit to help “break the stigma”. She said many employees were “silently suffering” and were either too embarrassed to broach the subject or experience a “lack of support” when they did. No one should feel their only option is to “turn their back on their career” over menopausal symptoms, she added. “It’s our responsibility as leaders to ensure this doesn’t happen any longer.” The guidance aims to boost awareness as well as support the introduction of practical measures including flexible working patterns – including lighter duties, fans to make temperatures more comfortable, cooler uniforms and staff training. “Our guidance has been intentionally designed to be transferable to other workplaces too, so I hope organisations and women beyond the NHS can also benefit,” she said. Read full story Source: The Guardian, 23 November 2022
  7. Content Article
    Recommendations All healthcare organisations should introduce flexible working arrangements for individual clinicians, with policies and procedures to ensure those affected can seek support – such as making reasonable workplace adjustments, taking breaks or taking time off when needed – without fear of adverse impacts on their career or professional reputation. Managers and senior leaders in the NHS/HSE and in private healthcare settings must be trained in the topic of the menopause, including the impact the symptoms can have on working females and their teams. Anyone who is suffering with menopause symptoms needs to be supported by their managers, to discuss any necessary changes to working arrangements. Occupational health teams should be involved in a proactive way in planning and supporting clinicians going through the menopause in a proactive way to avoid them leaving the profession. This should include support for mental health and wellbeing. We support the recommendation from the Health and Social Care Select Committee that all new doctors joining the profession should be trained on the menopause, however we would like to see this extended to currently practising doctors. Primary care providers should consider staff with menopause expertise, when hiring new team members, as this will benefit patients, clinicians and practice staff. Healthcare professionals working in the NHS/HSE or in private practice who are struggling with menopause symptoms themselves should seek support and professional advice on potential treatments and lifestyle measures. MPS also has a role to play – we listen to and care for members, including offering support with their wellbeing and we have made our 24/7 confidential counselling service available for those struggling with the menopause.
  8. News Article
    The NHS faces an “exodus” of female doctors who are struggling to work due to a lack of menopause support, a report has warned. The Medical Protection Society, which helps doctors in legal and ethical disputes, said that many quit or reduce their hours over fears that their menopause symptoms, such as brain fog, insomnia and hot flushes, will cause them to accidentally harm patients. A survey found that 36 per cent of female doctors have considered reducing their hours because of menopause symptoms, while one in five have considered early retirement. “With females making up most of the healthcare workforce, it is crucial that they can access the support they need to avoid an exodus from the profession,” the report said. Read full story (paywalled) Source: The Times, 26 October 2022
  9. Content Article
    Last week the The All Party Parliamentary Group (APPG) on Menopause published its final long-awaited report following a year-long inquiry into the menopause. The findings demonstrate that widespread action is needed to improve the situation for those going through the menopause. The report makes for a sobering read; women are facing obstacles to good menopause care and are often left feeling frustrated and unheard, with severe symptoms that impact on their careers, home life and relationships. This is particularly so for those women who undergo a hysterectomy or oophorectomy (a surgical procedure to remove one or both ovaries) which immediately sends a woman into surgical menopause. Unlike natural menopause, the onset of surgical menopause is often very sudden and abrupt. The British Menopause Society states that all women undergoing surgical menopause should have counselling and be provided with information about the hormonal consequences of surgery and the role of hormone replacement therapy (HRT), both before surgery and before leaving hospital, with clear communication to the primary care team. But many women, myself included, have said they received little or no information about the menopause before undergoing surgery. I had breast cancer and during treatment found out I had the BRCA1 gene mutation which made me high risk for developing ovarian cancer. I was advised to have an oophorectomy. I was referred to a gynaecologist and whilst I received all the appropriate information about the surgery itself, the benefits and risk of having surgery, I received no information about the surgical menopause it would put me in after. When I asked about this, I was told that I would naturally be going through the menopause in a few years anyway and that I was ‘lucky’ as I would miss out the years of perimenopause that most women go through. I felt my concerns were dismissed, but having gone through cancer once I wanted to lower my risk of going through it again so decided to go ahead with the operation. What I was not told, and didn't find out until after my surgery, was that women who enter premature menopause due to surgery (or chemically induced menopause due to treatments such as chemotherapy) tend to experience a severe and wide range of symptoms. As one woman on a surgical menopause support group I belong to put it: “A surgical menopause is like standing on the cliff edge and someone just pushing you off so you hit the ground below at full speed with a thud. There’s no parachute as in natural menopause to slow it down.” Due to the sudden loss of ovarian function in surgical menopause, pre-menopausal women might experience more severe consequences, including increased rates of overall mortality, coronary heart disease, stroke, cognitive impairment, osteoporosis and sexual dysfunction because of the lower levels of oestrogen and testosterone. It’s quite different from natural menopause, which is gradual and leaves some residual hormones in the body. Surely this is a patient safety issue if women are not being given all the information about surgical menopause? How can they make an informed decision on whether to have the surgery or not? I was followed up a couple of months after my surgery with a call from my gynaecologist to discuss how I was recovering from the surgery, but still was given no information on where to get help with the menopause. I was told I probably couldn’t take HRT because of my cancer but if I wanted to discuss this further to see my GP. After doing my own research on surgical menopause and joining some support groups online, I realised I was not alone in this, and many women currently receive zero post-surgical aftercare from the NHS for the menopause. “Women often enter surgical menopause with an urgent surgery and no time to prepare. This leaves them scrambling for information once they are already in the throes of menopause. They don’t know who to turn to and are often passed from oncologist/consultant, to gynaecologist, to GP.” There is a huge amount of misinformation and different opinions – even among medical professionals – that often lead to women being given incorrect information or no information at all. Oncologists will often advise against HRT for women, however they offer them no alternative or support. “In the aftermath of my surgery I was numb. I had not been warned of the symptoms of the menopause I’d feel, only the surgery. I didn’t know where to turn to. My oncologist wasn’t interested as I’d finished my breast cancer treatment. I was referred back to my GP but they didn’t know what to recommend.” Many women post-surgery end up in a crisis situation due to being so chronically hormone deficient. Some are left unable to work and unable to function, having experienced a severe deterioration in both physical and mental health. Their symptoms are not acknowledged by healthcare professionals and they are left with no aftercare or support. This is often on top of the physical and psychological toll of going through cancer treatment. “My life changed. I felt suicidal. If I’d known this, I may have taken the risk of not having surgery as my quality of life has deteriorated.” The APPG report has made a number of recommendations around access to HRT. However, there are currently no specific supporting NICE guidelines in place to help healthcare professionals manage and support women in surgical menopause and those who need closer management due to hormone sensitivities and when mainstream methods of HRT fail. Whilst I’m encouraged that the APPG report highlights alternatives to HRT for those who choose not to take it or who are not recommended to, it acknowledges that the evidence on the effectiveness of CBT, complementary and holistic treatments or herbal therapies is unclear and often disputed within the menopause community. Alternative treatments are unable to treat a wide range of menopause symptoms in the way that HRT can. GPs must be educated on social prescribing, and greater collaboration between the complementary therapies sector and GPs is needed to make them aware of the range of options they can offer women to treat and support them during menopause. Many women are forced to seek specialist private care in order to regain any form of quality of life, however ultimately this comes at a financial cost which not everyone can afford. Although I welcome the APPG report, more needs to be done for women who find themselves going through surgical menopause, often at a younger age than natural menopause. Here's what I'd like to see available for all women: Information pre-surgery about the hormonal consequences of surgery. Information on the risks and benefits of surgery, so that the patient can make an informed decision. The option of counselling before or after surgery. Follow up after the surgery specifically on the menopausal symptoms patients may be facing. More information on the risk and benefits of HRT for women who have had cancer, and alternative options if the woman cannot take HRT. A key specialist contact post-surgery who has had the appropriate training and expertise to advise on the menopause. Access to a specialist menopause centre.
  10. News Article
    Women should be invited for a menopause check-up when they turn 45, a report for MPs says, criticising the current support as completely inadequate. The Menopause All-Party Parliamentary Group says it has listened carefully to women's experiences, including difficulties getting a diagnosis and accessing hormone-replacement therapy (HRT). Many had long waits or were offered antidepressants, against guidelines. The report covers a year-long inquiry. It says action is needed to improve the situation for those going through the menopause, and the families, friends and colleagues affected by it. And a health check offered to all women in their mid-40s, as they approach the perimenopause - when hormones decline and menopausal symptoms, such as hot flushes and night sweats, can begin - should help ensure the necessary support and care as early as possible. The inquiry heard a 39-year-old who suspected she was perimenopausal was turned away by her GP and told to "wait and see". Some 18 months later, she was "almost at the verge of collapsing, struggling to keep my usually happy marriage on track and not functioning well physically or mentally". The report also warns a socio-economic divide is emerging between women able to access the right treatment and those who lose out in the postcode lottery and do not have the financial means to seek treatment elsewhere. Read full story Source: BBC News, 12 October 2022
  11. Content Article
    Recommendations The Group makes 13 recommendations for Government, NHS and other bodies to initiate change and dispel the long-held taboo around ‘the change’, including to: Urgently scrap prescription costs for HRT in England, as is the case in all the devolved nations. Implement a health check for all women at 45 to help diagnose menopause at an earlier stage. Fund new research into the real benefits of HRT and the link between menopause and serious health conditions. Co-ordinate an employer-led campaign and improve guidance to drive up support for menopause in the workplace; Create a National Formulary for HRT and include menopause in the GP Quality and Outcomes Framework to improve menopause diagnosis and treatment. Provide updated menopause training for GPs and other healthcare professionals who did not receive it in the past, in addition to the forthcoming medical assessment for incoming doctors.
  12. News Article
    Previously offered as prescription only, estradiol tablets, sold under the brand name Gina10, will now be available to women over the age of 50 who have not had a period for more than a year, as part of hormone replacement therapy treatment (HRT). Pharmacists have been offered training to identify who needs the tablets. The Medicines and Healthcare products Regulatory Agency (MHRA) made the decision as part of a strategy to make menopause treatment more accessible for women. Estradiol tablets treat vaginal symptoms caused by a lack of oestrogen, such as dryness, soreness, itching, burning and uncomfortable sex. The product is inserted into the vagina rather than taken by mouth. MHRA chief healthcare quality and access officer Dr Laura Squire called the move a "landmark reclassification for millions of women in the UK". "In reaching this decision, we have seen positive support from a wide range of people, including many women aged 50 years and above who could benefit from this decision," she said. The MHRA hopes the move will relieve pressure on front-line NHS services and give women more freedom in choosing treatments that work for them. Read full story Source: BBC News, 8 September 2022
  13. Content Article
    The handbook covers the following topics: The Yentl Syndrome Heart disease Stroke Autoimmune disease Dementia Cancer Handling your health Helping women be heard Who’s an expert on your body? Menstruation Pregnancy Infertility Menopause Mental health
  14. Content Article
    Key findings Pregnant women in prison are more likely to experience preterm labour than women in the general population. There are no official data on the number of women in prison who have children. Our work can fill in some of this gap. In 2019/20, 212 women had given birth in hospital within the four years before going to prison, 109 within the two years before. Access to hospital services is poor and this is a long-term issue. Hospital data highlight the complex needs of women in prison, particularly around trauma and substance misuse. Substance misuse plays a part in a significant proportion of hospital admissions by women in prison. Women’s sexual and reproductive health care needs are not talked about openly and symptoms of normal changes to the body, such as the menopause, as well as conditions such as endometriosis, are not well understood or managed. Key recommendations Ensure women have access to good-quality, understandable and targeted health care information. Commit to better data collection to inform planning and address inequality. Better understand and address the needs of those with children as an urgent priority ahead of the new prison places. Acknowledge and address the range of reasons why hospital appointments might be missed.
  15. Content Article
    The 6-point plan Within the next 10 years, the Women’s Health Strategy for England will have: boosted health outcomes for all women and girls radically improved the way in which the health and care system engages and listens to all women and girls. It will achieve this by: taking a life course approach focusing on women’s health policy and services throughout their lives embedding hybrid and wrap-around services as best practice boosting the representation of women’s voices and experiences in policy-making, and at all levels of the health and care system. It will bring together everyone across the healthcare system to act as the catalyst for the long-term change we all want to see. The strategy builds on 'Our Vision for the Women’s Health Strategy for England', which was published in December 2021, and sets out ambitions for improving the health and wellbeing of women and girls in England based on the life course approach, and resetting how the health and care system listens to women. This strategy sets out how it will go further with the 6-point long-term plan for transformational change: Ensuring women’s voices are heard – tackling taboos and stigmas, ensuring women are listened to by healthcare professionals, and increasing representation of women at all levels of the health and care system. Improving access to services – ensuring women can access services that meet their reproductive health needs across their lives, and prioritising services for women’s conditions such as endometriosis. Ensuring conditions that affect both men and women, such as autism or dementia, consider women’s needs by default, and being clear on how conditions affect men and women differently. Addressing disparities in outcomes among women – ensuring that a woman’s age, ethnicity, sexuality, disability or where she is from does not impact upon her ability to access services, or the treatment she receives. Better information and education – enabling women and wider society to easily equip themselves with accurate information about women’s health, and healthcare professionals to have the initial and ongoing training they need to treat their patients knowledgably and empathetically. Greater understanding of how women’s health affects their experience in the workplace – normalising conversations on taboo topics, such as periods and the menopause, to ensure women can remain productive and be supported in the workplace, and highlighting the many examples of good practice by employers. Supporting more research, improving the evidence base and spearheading the drive for better data – addressing the lack of research into women’s health conditions, improving the representation of women of all demographics in research, and plugging the data gap and ensuring existing data is broken down by sex. The strategy goes on to set out its approach to priority areas related to specific conditions or areas of health where the call for evidence highlighted particular issues or opportunities: menstrual health and gynaecological conditions fertility, pregnancy, pregnancy loss and postnatal support menopause mental health and wellbeing cancers the health impacts of violence against women and girls healthy ageing and long-term conditions.
  16. Content Article
    Key findings show: One in ten women who worked during the menopause have left a job due to their symptoms. Eight out of ten women say their employer hasn’t shared information, trained staff, or put in place a menopause absence policy. Almost half of women haven’t approached their GPs and three in ten have seen delays in diagnosis. Only four in ten women were offered HRT in a timely fashion. The report calls for: Employers to have menopause action plans Make flexible work the default Implement a public information campaign and invite every woman in to speak with her GP about menopause at an appropriate age Ensure GPs receive mandatory training to help diagnose menopause earlier.
  17. Content Article
    Key themes raised in the evidence include: Menstrual health and gynaecological conditions, including period poverty and the impact of menstruation on everyday life, whether or not it is painful and heavy. Sexual health and contraception, including barriers to accessing information for particular groups of women and geographical variation in the commissioning of services. Fertility, pregnancy, pregnancy loss and maternal health, including lack of information about factors affecting fertility and options for treatment. Variations in access to IVF were also raised, as well as the issues of disparities in maternal and neonatal outcomes and women not feeling heard during and after pregnancy. The menopause, including gaps in training and guidance for healthcare professionals and the impact of menopause symptoms on women's employment and opportunities. Gynaecological and other cancers, including a lack of high-quality, up-to-date information on risk factors and symptoms of female cancers, misdiagnosis and lack of personalised care. Some responses also raised the issue of trauma associated with cervical screening and other gynaecological procedures as a result of previous sexual assault or trauma. Mental health, including how women's health conditions can interact with and affect mental wellbeing across the life course, and lack of access to appropriate mental health support at the point of need. Healthy ageing and other conditions, including a lack of focus on the needs and concerns of older women, such as incontinence and osteoporosis. Some responses also raised the issue of a lack of understanding and recognition of how women may experience health conditions in different ways to men. Violence against women and girls, including the impact of and complications associated with procedures such as hymenoplasty that are still prevalent amongst some cultural groups. Some responses also raised the fact that women who have been subject to abuse and violence face significant additional barriers to accessing healthcare. A wide range of recommendations to improve women’s health outcomes and service provision were shared in the responses. Some key themes of these recommendations include: Increase public awareness of women’s health topics and improve access to high-quality information in digital and non-digital formats. Introduce and update legislation to better protect women and improve service quality. Ensure national guidelines are fully and consistently implemented, and extended where necessary to address important gaps. Improve healthcare professionals’ education and continuous development to better listen to and support women. Prioritise integrated, holistic, and user-centred care models to respond to the varying needs of women across the life course. Increase funding to improve women’s health services and address disparities between men and women, and different groups of women. Increase funding to improve women’s health services and address disparities between men and women, and different groups of women. Related reading Patient Safety Learning: Women’s Health Strategy Consultation Response Medicines, research and female hormones: a dangerous knowledge gap Dangerous exclusions: The risk to patient safety of sex and gender bias (Patient Safety Learning, March 2021)
  18. Content Article
    Priority topics The top 5 topics respondents want DHSC to prioritise for inclusion are: gynaecological conditions (63%) fertility, pregnancy, pregnancy loss and postnatal support (55%) the menopause (48%) menstrual health (47%) mental health (39%). This selection varies most notably by age, with topics rising in importance as they correspond with each stage of a woman’s life course. Other popular topics include research into health issues or medical conditions that affect women (34%), gynaecological cancers (30%), and the health impacts of violence against women and girls (30%).
  19. News Article
    A third of women who have suffered symptoms of the menopause say they hid them at work, and many think there remains a stigma around talking about the subject, according to a survey of workers in five countries. More than 5,000 women in the UK, Germany, Spain, Italy and South Africa were interviewed about their experiences of the menopause and work in research for the mobile phone provider Vodafone. In all of the countries except Italy, about a third said they had hidden symptoms, while in Spain more than half felt a stigma around the subject in the workplace. South African women seemed most comfortable discussing the subject with colleagues, with 37% saying they thought there was a stigma, while in Italy the proportion who said they had hidden symptoms was lowest at 28%. The survey found those who experienced symptoms before they were 45 were most likely to say that they were too embarrassed to ask for support in the workplace. Of those in the UK, 63% of adults under the age of 44 said they had shied away from asking for help, while across all ages the figure was 43%. The figures were similar in the four other countries. In recent years, businesses have begun to introduce policies to help women who are suffering from menopausal symptoms such as hot flushes, anxiety and fatigue. However, there are concerns that many women are still leaving the workforce because they struggle with some of the effects, and feel they are not supported by their employers. Read full story Source: The Guardian, 8 March 2021
×